Dendritic cells: therapy and imaging

Bibliography

• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52
   PubMed Web of Science ®Google Scholar
• Larsson M, Majeed M, Ernst JD, et al. Role of annexins in endocytosis of antigens in immature human dendritic cells. Immunology 1997;92:501-11
   PubMed Web of Science ®Google Scholar
• Ni K, O'Neill HC. The role of dendritic cells in T cell activation. Immunol Cell Biol 1997;75:223-30
   PubMed Web of Science ®Google Scholar
• Bergstresser PR, Fletcher CR, Streilein JW. Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties. J Invest Dermatol 1980;74:77-80
   PubMed Web of Science ®Google Scholar
• Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997;9:10-16
   PubMed Web of Science ®Google Scholar
• Katz SI, Cooper KD, Iijima M, Tsuchida T. The role of Langerhans cells in antigen presentation. J Invest Dermatol 1985;85:96s-8s
   PubMed Web of Science ®Google Scholar
• Nunez R. Revision of the functional analysis and structural features of immortalized dendritic cell lines derived from mice lacking both type I and type II interferon receptors. Immunol Lett 1999;68:173-86
   PubMed Web of Science ®Google Scholar
• Mendelson M, Hanekom WA, Ntutela S, et al. Quantitative and functional differences between peripheral blood myeloid dendritic cells from patients with pleural and parenchymal lung tuberculosis. Clin Vaccine Immunol 2006;13:1299-306
   PubMed Web of Science ®Google Scholar
• Sherr DH, Cheung NK, Heghinian KM, et al. Immune suppression in vivo with antigen-modified syngeneic cells. II. T cell-mediated nonresponsiveness to fowl γ-globulin. J Immunol 1979;122:1899-904
   PubMed Web of Science ®Google Scholar
• Ko BK, Kawano K, Murray JL, et al. Clinical studies of vaccines targeting breast cancer. Clin Cancer Res 2003;9:3222-34
   PubMed Web of Science ®Google Scholar
• Anichini A, Fossati G, Parmiani G. Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma. Int J Cancer 1985;35:683-9
   PubMed Web of Science ®Google Scholar
• Barnd DL, Kerr LA, Metzgar RS, Finn OJ. Human tumor-specific cytotoxic T cell lines generated from tumor-draining lymph node infiltrate. Transplant Proc 1988;20:339-41
   PubMedGoogle Scholar
• Knuth A, Wolfel T, Klehmann E, et al. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc Natl Acad Sci USA 1989;86:2804-8
   PubMed Web of Science ®Google Scholar
• Muul LM, Spiess PJ, Director EP, Rosenberg SA. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J Immunol 1987;138:989-95
   PubMed Web of Science ®Google Scholar
• Slovin SF, Lackman RD, Ferrone S, et al. Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity. J Immunol 1986;137:3042-8
   PubMed Web of Science ®Google Scholar
• Badoual C, Hans S, Rodriguez J, et al. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res 2006;12:465-72
   PubMed Web of Science ®Google Scholar
• Balch CM, Riley LB, Bae YJ, et al. Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg 1990;125:200-5
   PubMed Web of Science ®Google Scholar
• House AK, Watt AG. Survival and the immune response in patients with carcinoma of the colorectum. Gut 1979;20:868-74
   PubMed Web of Science ®Google Scholar
• Mukai S, Kjaergaard J, Shu S, Plautz GE. Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy. Cancer Res 1999;59:5245-9
   PubMed Web of Science ®Google Scholar
• Willimsky G, Blankenstein T. Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors. Cancer Res 2000;60:685-92
   PubMed Web of Science ®Google Scholar
• Schiltz P, Dillman R. A theoretical approach for T-lymphocyte monitoring of autologous cancer vaccine therapy using autologous HLA-class I and HLA-class II constructs. Cancer Biother Radiopharm 2004;19:405-10
   PubMed Web of Science ®Google Scholar
• Steinman RM, Dhodapkar M. Active immunization against cancer with dendritic cells: the near future. Int J Cancer 2001;94:459-73
   PubMed Web of Science ®Google Scholar
• Thurner B, Haendle I, Roder C, et al. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 1999;190:1669-78
   PubMed Web of Science ®Google Scholar
• Wu L, Liu Y. Development of dendritic-cell lineages. Immunity 2007;26:741-50
   PubMed Web of Science ®Google Scholar
• Ema H, Suda T, Miura Y, Nakauchi H. Colony formation of clone-sorted human hematopoietic progenitors. Blood 1990;75:1941-6
   PubMed Web of Science ®Google Scholar
• Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994;180:83-93
   PubMed Web of Science ®Google Scholar
• Robinson S. Identification and immunophenotypic analyses of peripheral blood dendritic cells. In: Dendritic Cell Protocols. Robinson SP and Stagg AJ (editors), The Humana Press Inc. 2001. pp 99-100
   Google Scholar
• Bernhard H, Disis ML, Heimfeld S, et al. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res 1995;55:1099-104
   PubMed Web of Science ®Google Scholar
• Saraya K, Reid CD. Stem cell factor and the regulation of dendritic cell production from CD34+ progenitors in bone marrow and cord blood. Br J Haematol 1996;93:258-64
   PubMed Web of Science ®Google Scholar
• Sinha S, Anderson JP, Barbour R, et al. Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature 1999;402:537-40
   PubMed Web of Science ®Google Scholar
• Strobl H, Bello-Fernandez C, Riedl E, et al. flt3 ligand in cooperation with transforming growth factor-β1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood 1997;90:1425-34
   PubMed Web of Science ®Google Scholar
• Young JW, Szabolcs P, Moore MA. Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α. J Exp Med 1995;182:1111-9
   PubMed Web of Science ®Google Scholar
• Ito T, Inaba M, Inaba K, et al. A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J Immunol 1999;163:1409-19
   PubMed Web of Science ®Google Scholar
• Navarro-Sanchez E, Despres P, Cedillo-Barron L. Innate immune responses to dengue virus. Arch Med Res 2005;36:425-35
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhan Y, Lew AM, et al. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J Immunol 2007;179:7577-84
   PubMed Web of Science ®Google Scholar
• Hardy RR, Kincade PW, Dorshkind K. The protean nature of cells in the B lymphocyte lineage. Immunity 2007;26:703-14
   PubMed Web of Science ®Google Scholar
• Welner RS, Pelayo R, Kincade PW. Evolving views on the genealogy of B cells. Nat Rev Immunol 2008;8:95-106
   PubMed Web of Science ®Google Scholar
• Welner RS, Pelayo R, Nagai Y, et al. Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection. Blood 2008;112:3753-61
   PubMed Web of Science ®Google Scholar
• Wu L, Vremec D, Ardavin C, et al. Mouse thymus dendritic cells: kinetics of development and changes in surface markers during maturation. Eur J Immunol 1995;25:418-25
   PubMed Web of Science ®Google Scholar
• Maraskovsky E, Brasel K, Teepe M, et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med 1996;184:1953-62
   PubMed Web of Science ®Google Scholar
• Shurin MR, Pandharipande PP, Zorina TD, et al. FLT3 ligand induces the generation of functionally active dendritic cells in mice. Cell Immunol 1997;179:174-84
   PubMed Web of Science ®Google Scholar
• Randolph GJ, Ochando J, Partida-Sanchez S. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol 2008;26:293-316
   PubMed Web of Science ®Google Scholar
• Kissenpfennig A, Henri S, Dubois B, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005;22:643-54
   PubMed Web of Science ®Google Scholar
• Vremec D, Shortman K. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J Immunol 1997;159:565-73
   PubMed Web of Science ®Google Scholar
• Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007;7:19-30
   PubMed Web of Science ®Google Scholar
• Smith AL, de St Groth BF. Antigen-pulsed CD8α+ dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node. J Exp Med 1999;189:593-8
   PubMed Web of Science ®Google Scholar
• Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005;23:275-306
   PubMed Web of Science ®Google Scholar
• van Nierop K, de Groot C. Human follicular dendritic cells: function, origin and development. Semin Immunol 2002;14:251-7
   PubMed Web of Science ®Google Scholar
• Angeli V, Ginhoux F, Llodra J, et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 2006;24:203-15
   PubMed Web of Science ®Google Scholar
• Allan RS, Smith CM, Belz GT, et al. Epidermal viral immunity induced by CD8α+ dendritic cells but not by Langerhans cells. Science 2003;301:1925-8
   PubMed Web of Science ®Google Scholar
• Allan RS, Waithman J, Bedoui S, et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006;25:153-62
   PubMed Web of Science ®Google Scholar
• Zhao X, Deak E, Soderberg K, et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med 2003;197:153-62
   PubMed Web of Science ®Google Scholar
• Kamath AT, Henri S, Battye F, et al. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 2002;100:1734-41
   PubMed Web of Science ®Google Scholar
• Hemmi H, Yoshino M, Yamazaki H, et al. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-β1-dependent cells. Int Immunol 2001;13:695-704
   PubMed Web of Science ®Google Scholar
• Steinman RM, Nussenzweig MC. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 2002;99:351-8
   PubMed Web of Science ®Google Scholar
• Chen M, Huang L, Shabier Z, Wang J. Regulation of the lifespan in dendritic cell subsets. Mol Immunol 2007;44:2558-65
   PubMed Web of Science ®Google Scholar
• Ingulli E, Mondino A, Khoruts A, Jenkins MK. In vivo detection of dendritic cell antigen presentation to CD4+ T cells. J Exp Med 1997;185:2133-41
   PubMed Web of Science ®Google Scholar
• O'Keeffe M, Hochrein H, Vremec D, et al. Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8+ dendritic cells only after microbial stimulus. J Exp Med 2002;196:1307-19
   PubMed Web of Science ®Google Scholar
• Hou WS, Van Parijs L. A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat Immunol 2004;5:583-9
   PubMed Web of Science ®Google Scholar
• Kim TW, Lee JH, He L, et al. Modification of professional antigen-presenting cells with small interfering RNA in vivo to enhance cancer vaccine potency. Cancer Res 2005;65:309-16
   PubMed Web of Science ®Google Scholar
• Peng S, Kim TW, Lee JH, et al. Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life. Hum Gene Ther 2005;16:584-93
   PubMed Web of Science ®Google Scholar
• Pirtskhalaishvili G, Shurin GV, Gambotto A, et al. Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice. J Immunol 2000;165:1956-64
   PubMed Web of Science ®Google Scholar
• Grolleau A, Sloan A, Mule JJ. Dendritic cell-based vaccies for cancer therapy. In: Samir Khleif, editor, Tumor Immunology and Cancer Vaccines 2005. p. 181-205
   Google Scholar
• Inaba K, Inaba M, Naito M, Steinman RM. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 1993;178:479-88
   PubMed Web of Science ®Google Scholar
• Moll H, Fuchs H, Blank C, Rollinghoff M. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur J Immunol 1993;23:1595-601
   PubMed Web of Science ®Google Scholar
• Reis E, Sousa C, Stahl PD, Austyn JM. Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med 1993;178:509-19
   PubMed Web of Science ®Google Scholar
• Svensson M, Stockinger B, Wick MJ. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells. J Immunol 1997;158:4229-36
   PubMed Web of Science ®Google Scholar
• Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995;182:389-400
   PubMed Web of Science ®Google Scholar
• Pham W, Xie J, Gore JC. Tracking the migration of dendritic cells by in vivo optical imaging. Neoplasia 2007;9:1130-7
   PubMed Web of Science ®Google Scholar
• Cella M, Scheidegger D, Palmer-Lehmann K, et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996;184:747-52
   PubMed Web of Science ®Google Scholar
• Koch F, Stanzl U, Jennewein P, et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 1996;184:741-6
   PubMed Web of Science ®Google Scholar
• Winzler C, Rovere P, Rescigno M, et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 1997;185:317-28
   PubMed Web of Science ®Google Scholar
• Clark GJ, Angel N, Kato M, et al. The role of dendritic cells in the innate immune system. Microbes Infect 2000;2:257-72
   PubMed Web of Science ®Google Scholar
• Diebold SS. Activation of dendritic cells by Toll-like receptors and C-type lectins. Handb Exp Pharmacol 2009;3-30
   PubMedGoogle Scholar
• Napper CE, Taylor ME. The mannose receptor fails to enhance processing and presentation of a glycoprotein antigen in transfected fibroblasts. Glycobiology 2004;14:7C-12C
   PubMed Web of Science ®Google Scholar
• Akira S, Yamamoto M, Takeda K. Role of adapters in Toll-like receptor signalling. Biochem Soc Trans 2003;31:637-42
   PubMed Web of Science ®Google Scholar
• Robalino J, Browdy CL, Prior S, et al. Induction of antiviral immunity by double-stranded RNA in a marine invertebrate. J Virol 2004;78:10442-8
   PubMed Web of Science ®Google Scholar
• Reis e Sousa C, Germain RN. Analysis of adjuvant function by direct visualization of antigen presentation in vivo endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue. J Immunol 1999;162:6552-61
   PubMed Web of Science ®Google Scholar
• Rutella S, Danese S, Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 2006;108:1435-40
   PubMed Web of Science ®Google Scholar
• Yanagawa Y, Onoe K. Enhanced IL-10 production by TLR4- and TLR2-primed dendritic cells upon TLR restimulation. J Immunol 2007;178:6173-80
   PubMed Web of Science ®Google Scholar
• Morelli A, Larregina A, Chuluyan I, et al. Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotactic effect of C5a on skin migratory dendritic cells. Immunology 1996;89:126-34
   PubMed Web of Science ®Google Scholar
• Fanger NA, Voigtlaender D, Liu C, et al. Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor Fc gamma RI (CD64) expressed on human blood dendritic cells. J Immunol 1997;158:3090-8
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-18
   PubMed Web of Science ®Google Scholar
• Granucci F, Vizzardelli C, Pavelka N, et al. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2001;2:882-8
   PubMed Web of Science ®Google Scholar
• Gerosa F, Baldani-Guerra B, Nisii C, et al. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002;195:327-33
   PubMed Web of Science ®Google Scholar
• Diebold SS. Determination of T-cell fate by dendritic cells. Immunol Cell Biol 2008;86:389-97
   PubMed Web of Science ®Google Scholar
• Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-96
   PubMed Web of Science ®Google Scholar
• Granucci F, Andrews DM, Degli-Esposti MA, Ricciardi-Castagnoli P. IL-2 mediates adjuvant effect of dendritic cells. Trends Immunol 2002;23:169-71
   PubMed Web of Science ®Google Scholar
• Fernandez NC, Lozier A, Flament C, et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999;5:405-11
   PubMed Web of Science ®Google Scholar
• Yang L, Carbone DP. Tumor–host immune interactions and dendritic cell dysfunction. Adv Cancer Res 2004;92:13-27
   PubMed Web of Science ®Google Scholar
• Kim R, Emi M, Tanabe K. Functional roles of immature dendritic cells in impaired immunity of solid tumour and their targeted strategies for provoking tumour immunity. Clin Exp Immunol 2006;146:189-96
   PubMed Web of Science ®Google Scholar
• Moody DB, Briken V, Cheng TY, et al. Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nat Immunol 2002;3:435-42
   PubMed Web of Science ®Google Scholar
• August A, Dupont B. Activation of extracellular signal-regulated protein kinase (ERK/MAP kinase) following CD28 cross-linking: activation in cells lacking p56lck. Tissue Antigens 1995;46:155-62
   PubMed Web of Science ®Google Scholar
• Ganong WF. Circulation body fluids. In: Review of Medical Physiology (19th edition). Appleton & Lange. 1997. pp 502
   Google Scholar
• Beckebaum S, Zhang X, Chen X, et al. Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Clin Cancer Res 2004;10:7260-9
   PubMed Web of Science ®Google Scholar
• Bellone G, Carbone A, Smirne C, et al. Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells. J Immunol 2006;177:3448-60
   PubMed Web of Science ®Google Scholar
• Della Bella S, Gennaro M, Vaccari M, et al. Altered maturation of peripheral blood dendritic cells in patients with breast cancer. Br J Cancer 2003;89:1463-72
   PubMed Web of Science ®Google Scholar
• Enk AH, Jonuleit H, Saloga J, Knop J. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer 1997;73:309-16
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Chen HL, Girgis KR, et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 1996;2:1096-103
   PubMed Web of Science ®Google Scholar
• Garrity T, Pandit R, Wright MA, et al. Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells. Int J Cancer 1997;73:663-9
   PubMed Web of Science ®Google Scholar
• Gorham ED, Garland CF, Garland FC, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 2007;32:210-6
   PubMed Web of Science ®Google Scholar
• Huang A, Gilmour JW, Imami N, et al. Increased serum transforming growth factor-β1 in human colorectal cancer correlates with reduced circulating dendritic cells and increased colonic Langerhans cell infiltration. Clin Exp Immunol 2003;134:270-8
   PubMed Web of Science ®Google Scholar
• Kuang DM, Zhao Q, Xu J, et al. Tumor-educated tolerogenic dendritic cells induce CD3ϵ down-regulation and apoptosis of T cells through oxygen-dependent pathways. J Immunol 2008;181:3089-98
   PubMed Web of Science ®Google Scholar
• Menetrier-Caux C, Montmain G, Dieu MC, et al. Inhibition of the differentiation of dendritic cells from CD34+ progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 1998;92:4778-91
   PubMed Web of Science ®Google Scholar
• Ohm JE, Carbone DP. VEGF as a mediator of tumor-associated immunodeficiency. Immunol Res 2001;23:263-72
   PubMed Web of Science ®Google Scholar
• Pak AS, Wright MA, Matthews JP, et al. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34+ cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor. Clin Cancer Res 1995;1:95-103
   PubMed Web of Science ®Google Scholar
• Peguet-Navarro J, Sportouch M, Popa I, et al. Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis. J Immunol 2003;170:3488-94
   PubMed Web of Science ®Google Scholar
• Penna G, Adorini L. 1α,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000;164:2405-11
   PubMed Web of Science ®Google Scholar
• Shurin GV, Shurin MR, Bykovskaia S, et al. Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res 2001;61:363-9
   PubMed Web of Science ®Google Scholar
• Sombroek CC, Stam AG, Masterson AJ, et al. Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J Immunol 2002;168:4333-43
   PubMed Web of Science ®Google Scholar
• Steinbrink K, Jonuleit H, Muller G, et al. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8+ T cells resulting in a failure to lyse tumor cells. Blood 1999;93:1634-42
   PubMed Web of Science ®Google Scholar
• Young MR, Wright MA, Lozano Y, et al. Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells. Int J Cancer 1997;74:69-74
   PubMed Web of Science ®Google Scholar
• Zea AH, Rodriguez PC, Atkins MB, et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res 2005;65:3044-8
   PubMed Web of Science ®Google Scholar
• Restifo NP, Esquivel F, Kawakami Y, et al. Identification of human cancers deficient in antigen processing. J Exp Med 1993;177:265-72
   PubMed Web of Science ®Google Scholar
• Costello R, Mallet F, Chambost H, et al. The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38– leukemic progenitors. Leukemia 1999;13:1513-8
   PubMed Web of Science ®Google Scholar
• Costello RT, Gastaut JA, Olive D. Tumor escape from immune surveillance. Arch Immunol Ther Exp (Warsz) 1999;47:83-8
   PubMedGoogle Scholar
• Almand B, Clark JI, Nikitina E, et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 2001;166:678-89
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Corak J, Ciernik IF, et al. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 1997;3:483-90
   PubMed Web of Science ®Google Scholar
• Pinzon-Charry A, Maxwell T, Lopez JA. Dendritic cell dysfunction in cancer: a mechanism for immunosuppression. Immunol Cell Biol 2005;83:451-61
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Ciernik IF, Carbone DP. Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts. Cell Immunol 1996;170:101-10
   PubMed Web of Science ®Google Scholar
• Pinzon-Charry A, Maxwell T, Mcguckin MA, et al. Spontaneous apoptosis of blood dendritic cells in patients with breast cancer. Breast Cancer Res 2006;8:R5. Published online 16 December 2005, doi:10.1186/bcr1361
   PubMed Web of Science ®Google Scholar
• Dikov MM, Ohm JE, Ray N, et al. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation. J Immunol 2005;174:215-22
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Schmitt E, Steinbrink K, Enk AH. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001;22:394-400
   PubMed Web of Science ®Google Scholar
• Czerniecki BJ, Roses RE, Koski GK. Development of vaccines for high-risk ductal carcinoma in situ of the breast. Cancer Res 2007;67:6531-4
   PubMed Web of Science ®Google Scholar
• Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-32
   PubMed Web of Science ®Google Scholar
• Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005;5:296-306
   PubMed Web of Science ®Google Scholar
• Bakker AB, van der Burg SH, Huijbens RJ, et al. Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope. Int J Cancer 1997;70:302
   PubMed Web of Science ®Google Scholar
• Brossart P, Heinrich KS, Stuhler G, et al. Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies. Blood 1999;93:4309-17
   PubMed Web of Science ®Google Scholar
• Chen JL, Dunbar PR, Gileadi U, et al. Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL. J Immunol 2000;165:948-55
   PubMed Web of Science ®Google Scholar
• Coulie PG, Brichard V, Van Pel A, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994;180:35-42
   PubMed Web of Science ®Google Scholar
• Graff-Dubois S, Faure O, Gross DA, et al. Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broad-spectrum tumor immunotherapy. J Immunol 2002;169:575-80
   PubMed Web of Science ®Google Scholar
• Kawakami Y, Eliyahu S, Sakaguchi K, et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 1994;180:347-52
   PubMed Web of Science ®Google Scholar
• Peoples GE, Goedegebuure PS, Smith R, et al. Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. Proc Natl Acad Sci USA 1995;92:432-6
   PubMed Web of Science ®Google Scholar
• Romero P, Dutoit V, Rubio-Godoy V, et al. CD8+ T-cell response to NY-ESO-1: relative antigenicity and in vitro immunogenicity of natural and analogue sequences. Clin Cancer Res 2001;7:766s-772s
   PubMed Web of Science ®Google Scholar
• Schechter AL, Stern DF, Vaidyanathan L, et al. The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature 1984;312:513-6
   PubMed Web of Science ®Google Scholar
• Zaremba S, Barzaga E, Zhu M, et al. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen. Cancer Res 1997;57:4570-7
   PubMed Web of Science ®Google Scholar
• Baar J. Clinical applications of dendritic cell cancer vaccines. Oncologist 1999;4:140-4
   PubMedGoogle Scholar
• Frasca L, Piazza C, Piccolella E. CD4+ T cells orchestrate both amplification and deletion of CD8+ T cells. Crit Rev Immunol 1998;18:569-94
   PubMed Web of Science ®Google Scholar
• Graziano DF, Finn OJ. Tumor antigens and tumor antigen discovery. In: Tumor Immunology and Cancer Vaccines Samir Khleif (editor), Kluwer Academic Publishers. 2005. pp 89-111
   Google Scholar
• Chang AE, Redman BG, Whitfield JR, et al. A Phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer. Clin Cancer Res 2002;8:1021-32
   PubMed Web of Science ®Google Scholar
• de Vries IJ, Lesterhuis WJ, Barentsz JO, et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005;23:1407-13
   PubMed Web of Science ®Google Scholar
• Escobar A, Lopez M, Serrano A, et al. Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients. Clin Exp Immunol 2005;142:555-68
   PubMed Web of Science ®Google Scholar
• Girardi M, Berger CL, Wilson LD, et al. Transimmunization for cutaneous T cell lymphoma: a Phase I study. Leuk Lymphoma 2006;47:1495-503
   PubMed Web of Science ®Google Scholar
• Griffioen M, Borghi M, Schrier PI, et al. Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates. Cancer Immunol Immunother 2004;53:715-22
   PubMed Web of Science ®Google Scholar
• Hersey P, Halliday GM, Farrelly ML, et al. Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma. Cancer Immunol Immunother 2008;57:1039-51
   PubMed Web of Science ®Google Scholar
• Hsu FJ, Benike C, Fagnoni F, et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996;2:52-8
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Kuhn U, Muller G, et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997;27:3135-42
   PubMed Web of Science ®Google Scholar
• Kyte JA, Kvalheim G, Lislerud K, et al. T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells. Cancer Immunol Immunother 2007;56:659-75
   PubMed Web of Science ®Google Scholar
• Kyte JA, Mu L, Aamdal S, et al. Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA. Cancer Gene Ther 2006;13:905-18
   PubMed Web of Science ®Google Scholar
• Lau R, Wang F, Jeffery G, et al. Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma. J Immunother 2001;24:66-78
   PubMed Web of Science ®Google Scholar
• Mackensen A, Herbst B, Chen JL, et al. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells. Int J Cancer 2000;86:385-92
   PubMed Web of Science ®Google Scholar
• Ossenkoppele GJ, Stam AG, Westers TM, et al. Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cells. Leukemia 2003;17:1424-6
   PubMed Web of Science ®Google Scholar
• Palucka AK, Ueno H, Connolly J, et al. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity. J Immunother 2006;29:545-57
   PubMed Web of Science ®Google Scholar
• Panelli MC, Wunderlich J, Jeffries J, et al. Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100. J Immunother 2000;23:487-98
   PubMed Web of Science ®Google Scholar
• Ribas A, Glaspy JA, Lee Y, et al. Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy. J Immunother 2004;27:354-67
   PubMed Web of Science ®Google Scholar
• Schadendorf D, Ugurel S, Schuler-Thurner B, et al. Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized Phase III trial of the DC study group of the DeCOG. Ann Oncol 2006;17:563-70
   PubMed Web of Science ®Google Scholar
• Schuler-Thurner B, Schultz ES, Berger TG, et al. Rapid Induction of tumor-specific type 1 T helper in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J Exp Med 2002;195:1279-88
   PubMed Web of Science ®Google Scholar
• Smithers M, O'Connell K, MacFadyen S, et al. Clinical response after intradermal immature dendritic cell vaccination in metastatic melanoma is associated with immune response to particulate antigen. Cancer Immunol Immunother 2003;52:41-52
   PubMed Web of Science ®Google Scholar
• Trakatelli M, Toungouz M, Blocklet D, et al. A new dendritic cell vaccine generated with interleukin-3 and interferon-β induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients. Cancer Immunol Immunother 2006;55:469-74
   PubMed Web of Science ®Google Scholar
• Wen YJ, Ling M, Bailey-Wood R, Lim SH. Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myeloma. Clin Cancer Res 1998;4:957-62
   PubMed Web of Science ®Google Scholar
• Kyte JA, Gaudernack G. Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells. Cancer Immunol Immunother 2006;55:1432-42
   PubMed Web of Science ®Google Scholar
• Eggert AA, Schreurs MW, Boerman OC, et al. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res 1999;59:3340-5
   PubMed Web of Science ®Google Scholar
• Fong L, Brockstedt D, Benike C, et al. Dendritic cells injected via different routes induce immunity in cancer patients. J Immunol 2001;166:4254-9
   PubMed Web of Science ®Google Scholar
• De Vries IJ, Krooshoop DJ, Scharenborg NM, et al. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res 2003;63:12-7
   PubMed Web of Science ®Google Scholar
• Bhasin M, Raghava GP. Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine 2004;22:3195-204
   PubMed Web of Science ®Google Scholar
• Rammensee H, Bachmann J, Emmerich NP, et al. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999;50:213-9
   PubMed Web of Science ®Google Scholar
• Brusic V, Rudy G, Honeyman G, et al. Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics 1998;14:121-30
   PubMed Web of Science ®Google Scholar
• Akiyama Y, Tanosaki R, Inoue N, et al. Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells. J Transl Med 2005;3:4. published online 28 January 2005, doi:10.1186/1479-5876-3-4
   PubMedGoogle Scholar
• Jerome KR, Barnd DL, Bendt KM, et al. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 1991;51:2908-16
   PubMed Web of Science ®Google Scholar
• Matsuzaki A, Suminoe A, Hattori H, et al. Immunotherapy with autologous dendritic cells and tumor-specific synthetic peptides for synovial sarcoma. J Pediatr Hematol Oncol 2002;24:220-3
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Ohta K, Kawabuchi Y, et al. Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells. Anticancer Res 2005;25:2407-15
   PubMed Web of Science ®Google Scholar
• Kao JY, Zhang M, Chen CM, Chen JJ. Superior efficacy of dendritic cell-tumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer. Immunol Lett 2005;101:154-9
   PubMed Web of Science ®Google Scholar
• Ashley DM, Faiola B, Nair S, et al. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J Exp Med 1997;186:1177-82
   PubMed Web of Science ®Google Scholar
• Gilboa E, Vieweg J. Cancer immunotherapy with mRNA-transfected dendritic cells. Immunol Rev 2004;199:251-63
   PubMed Web of Science ®Google Scholar
• Markovic SN, Dietz AB, Greiner CW, et al. Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma. J Transl Med 2006;4:35. Published online 15 August 2006, doi:10.1186/1479-5876-4-35
   PubMed Web of Science ®Google Scholar
• Liu K. Dendritic cell, toll-like receptor, and the immune system. J Cancer Mol 2006;2:213-5
   Google Scholar
• Jure-Kunkel MN, Masters G, Girit E, et al. Antitumor activity of anti-CTLA-4 monoclonal antibody (mAb) in combination with ixabepilone in preclinical tumor models. J Clin Oncol 2008;26:3048
   Google Scholar
• Bousso P. T-cell activation by dendritic cells in the lymph node: lessons from the movies. Nat Rev Immunol 2008;8:675-84
   PubMed Web of Science ®Google Scholar
• Cahalan MD, Parker I, Wei SH, Miller MJ. Two-photon tissue imaging: seeing the immune system in a fresh light. Nat Rev Immunol 2002;2:872-80
   PubMed Web of Science ®Google Scholar
• Stoll S, Delon J, Brotz TM, Germain RN. Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science 2002;296:1873-6
   PubMed Web of Science ®Google Scholar
• von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003;3:867-78
   PubMed Web of Science ®Google Scholar
• Centonze VE, White JG. Multiphoton excitation provides optical sections from deeper within scattering specimens than confocal imaging. Biophys J 1998;75:2015-24
   PubMed Web of Science ®Google Scholar
• Gerritsen HC, De Grauw CJ. Imaging of optically thick specimen using two-photon excitation microscopy. Microsc Res Tech 1999;47:206-9
   PubMed Web of Science ®Google Scholar
• Helmchen F, Denk W. Deep tissue two-photon microscopy. Nat Methods 2005;2:932-40
   PubMed Web of Science ®Google Scholar
• Piston DW. The coming of age of two-photon excitation imaging for intravital microscopy. Adv Drug Deliv Rev 2006;58:770-2
   PubMed Web of Science ®Google Scholar
• Bousso P, Robey E. Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes. Nat Immunol 2003;4:579-85
   PubMed Web of Science ®Google Scholar
• Pozzi LA, Maciaszek JW, Rock KL. Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. J Immunol 2005;175:2071-81
   PubMed Web of Science ®Google Scholar
• Rescigno M, Winzler C, Delia D, et al. Dendritic cell maturation is required for initiation of the immune response. J Leukoc Biol 1997;61:415-21
   PubMed Web of Science ®Google Scholar
• Miller MJ, Hejazi AS, Wei SH, et al. T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. Proc Natl Acad Sci USA 2004;101:998-1003
   PubMed Web of Science ®Google Scholar
• Boissonnas A, Fetler L, Zeelenberg IS, et al. In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor. J Exp Med 2007;204:345-56
   PubMed Web of Science ®Google Scholar
• Butcher EC, Williams M, Youngman K, et al. Lymphocyte trafficking and regional immunity. Adv Immunol 1999;72:209-53
   PubMed Web of Science ®Google Scholar
• Mempel TR, Henrickson SE, Von Andrian UH. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 2004;427:154-9
   PubMed Web of Science ®Google Scholar
• Miller MJ, Wei SH, Parker I, Cahalan MD. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 2002;296:1869-73
   PubMed Web of Science ®Google Scholar
• Hugues S, Fetler L, Bonifaz L, et al. Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nat Immunol 2004;5:1235-42
   PubMed Web of Science ®Google Scholar
• Zinselmeyer BH, Dempster J, Gurney AM, et al. In situ characterization of CD4+ T cell behavior in mucosal and systemic lymphoid tissues during the induction of oral priming and tolerance. J Exp Med 2005;201:1815-23
   PubMed Web of Science ®Google Scholar
• Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way. Nat Med 2004;10:475-80
   PubMed Web of Science ®Google Scholar
• MartIn-Fontecha A, Sebastiani S, Hopken UE, et al. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 2003;198:615-21
   PubMed Web of Science ®Google Scholar
• Nair S, McLaughlin C, Weizer A, et al. Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation. J Immunol 2003;171:6275-82
   PubMed Web of Science ®Google Scholar
• Kim S, Lim YT, Soltesz EG, et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 2004;22:93-7
   PubMed Web of Science ®Google Scholar
• Noh YW, Lim YT, Chung BH. Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals. FASEB J 2008;22:3908-18
   PubMed Web of Science ®Google Scholar
• Hopkins TA, Seliger HH, White EH, Cass MH. The chemiluminescence of firefly luciferin. A model for the bioluminescent reaction and identification of the product excited state. J Am Chem Soc 1967;89:7148-50
   PubMed Web of Science ®Google Scholar
• Michelini E, Cevenini L, Mezzanotte L, et al. Combining intracellular and secreted bioluminescent reporter proteins for multicolor cell-based assays. Photochem Photobiol Sci 2008;7:212-7
   PubMed Web of Science ®Google Scholar
• Hardy J, Edinger M, Bachmann MH, et al. Bioluminescence imaging of lymphocyte trafficking in vivo. Exp Hematol 2001;29:1353-60
   PubMed Web of Science ®Google Scholar
• Welsh DK, Kay SA. Bioluminescence imaging in living organisms. Curr Opin Biotechnol 2005;16:73-8
   PubMed Web of Science ®Google Scholar
• Contag CH, Bachmann MH. Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 2002;4:235-60
   PubMed Web of Science ®Google Scholar
• Kim YJ, Dubey P, Ray P, et al. Multimodality imaging of lymphocytic migration using lentiviral-based transduction of a tri-fusion reporter gene. Mol Imaging Biol 2004;6:331-40
   PubMed Web of Science ®Google Scholar
• Schimmelpfennig CH, Schulz S, Arber C, et al. Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation. Am J Pathol 2005;167:1321-31
   PubMed Web of Science ®Google Scholar
• Kupiec-Weglinski JW, Austyn JM, Morris PJ. Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues. J Exp Med 1988;167:632-45
   PubMed Web of Science ®Google Scholar
• Suda T, Callahan RJ, Wilkenson RA, et al. Interferon-γ reduces Ia+ dendritic cell traffic to the lung. J Leukoc Biol 1996;60:519-27
   PubMed Web of Science ®Google Scholar
• Morse MA, Coleman RE, Akabani G, et al. Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res 1999;59:56-8
   PubMed Web of Science ®Google Scholar
• Quillien V, Moisan A, Carsin A, et al. Biodistribution of radiolabelled human dendritic cells injected by various routes. Eur J Nucl Med Mol Imaging 2005;32:731-41
   PubMed Web of Science ®Google Scholar
• Ridolfi R, Riccobon A, Galassi R, et al. Evaluation of in vivo labelled dendritic cell migration in cancer patients. J Transl Med 2004;2:27. published online 30 July 2004, doi:10.1186/1479-5876-2-27
   PubMedGoogle Scholar
• Blocklet D, Toungouz M, Kiss R, et al. 111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content. Eur J Nucl Med Mol Imaging 2003;30:440-7
   PubMed Web of Science ®Google Scholar
• Thompson M, Wall DM, Hicks RJ, Prince HM. In vivo tracking for cell therapies. Q J Nucl Med Mol Imaging 2005;49:339-48
   PubMed Web of Science ®Google Scholar
• Baumjohann D, Lutz MB. Non-invasive imaging of dendritic cell migration in vivo. Immunobiology 2006;211:587-97
   PubMed Web of Science ®Google Scholar
• Awasthi S, Awasthi V, Magee DM, Coalson JJ. Efficacy of antigen 2/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii. J Immunol 2005;175:3900-6
   PubMed Web of Science ®Google Scholar
• Olasz EB, Lang L, Seidel J, et al. Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging. J Immunol Methods 2002;260:137-48
   PubMed Web of Science ®Google Scholar
• Adonai N, Nguyen KN, Walsh J, et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis (N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci USA 2002;99:3030-5
   PubMed Web of Science ®Google Scholar
• Dubey P, Su H, Adonai N, et al. Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc Natl Acad Sci USA 2003;100:1232-7
   PubMed Web of Science ®Google Scholar
• Dodd SJ, Williams M, Suhan JP, et al. Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J 1999;76:103-9
   PubMed Web of Science ®Google Scholar
• Ye Q, Wu YL, Foley LM, et al. Longitudinal tracking of recipient macrophages in a rat chronic cardiac allograft rejection model with noninvasive magnetic resonance imaging using micrometer-sized paramagnetic iron oxide particles. Circulation 2008;118:149-56
   PubMed Web of Science ®Google Scholar
• Baumjohann D, Hess A, Budinsky L, et al. In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice. Eur J Immunol 2006;36:2544-55
   PubMed Web of Science ®Google Scholar
• Kobukai S, Baheza R, Xie J, et al. Development of magnetic nanoparticles for in vivo imaging the migration of dendritic cells. Magn Reson Med 2009 (In Press)
   Google Scholar
• Foster PJ, Dunn EA, Karl KE, et al. Cellular magnetic resonance imaging: in vivo imaging of melanoma cells in lymph nodes of mice. Neoplasia 2008;10:207-16
   PubMed Web of Science ®Google Scholar
• Josephson L, Tung CH, Moore A, Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 1999;10:186-91
   PubMed Web of Science ®Google Scholar
• Modo M, Cash D, Mellodew K, et al. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage 2002;17:803-11
   PubMed Web of Science ®Google Scholar
• Modo M, Mellodew K, Cash D, et al. Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage 2004;21:311-7
   PubMed Web of Science ®Google Scholar
• Louie AY, Huber MM, Ahrens ET, et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 2000;18:321-5
   PubMed Web of Science ®Google Scholar
• Moats RA, Fraser SE, Meade TJ. A “smart” magnetic resonance imaging agent that reports on specific enzymic activity. Angew Chem Int Ed Engl 1997;36:726-8
   Web of Science ®Google Scholar
• Himmelreich U, Aime S, Hieronymus T, et al. A responsive MRI contrast agent to monitor functional cell status. Neuroimage 2006;32:1142-9
   PubMed Web of Science ®Google Scholar
• Gao X, Yang L, Petros JA, et al. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 2005;16:63-72
   PubMed Web of Science ®Google Scholar
• Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med 2003;9:123-8
   PubMed Web of Science ®Google Scholar
• Gilad AA, Walczak P, McMahon MT, et al. MR tracking of transplanted cells with “positive contrast” using manganese oxide nanoparticles. Magn Reson Med 2008;60:1-7
   PubMed Web of Science ®Google Scholar
• Lim YT, Noh YW, Han JH, et al. Biocompatible polymer-nanoparticle-based bimodal imaging contrast agents for the labeling and tracking of dendritic cells. Small 2008;4:1640-5
   PubMed Web of Science ®Google Scholar